Lee Frank S, Percy Melanie J, McMullin Mary Frances
Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA.
Cell Cycle. 2006 May;5(9):941-5. doi: 10.4161/cc.5.9.2723. Epub 2006 May 1.
Idiopathic erythrocytosis (IE) is a rare condition in which there is an increase in red cell mass and hematocrit. As it is typically driven by elevated or inappropriately normal erythropoietin (Epo) levels, it has the potential to reveal the identities of proteins involved in the oxygen sensing pathway that regulates the transcription factor, Hypoxia Inducible Factor (HIF), and hence Epo production in humans. One example of this is provided by Chuvash polycythemia, a form of erythrocytosis due to a mutation in the von Hippel Lindau tumor suppressor protein (VHL), a component of an E3 ubiquitin ligase complex that targets hydroxylated HIF for degradation. A recent report of familial erythrocytosis now implicates a different protein, Prolyl Hydroxylase Domain protein 2 (PHD2), which is an enzyme that hydroxylates HIF.
特发性红细胞增多症(IE)是一种罕见病症,其特征为红细胞量和血细胞比容增加。由于它通常由促红细胞生成素(Epo)水平升高或异常正常所驱动,因此有可能揭示参与调节转录因子缺氧诱导因子(HIF)从而调控人类Epo生成的氧感应途径中相关蛋白质的身份。楚瓦什红细胞增多症就是一个例子,它是一种红细胞增多症,由冯·希佩尔-林道肿瘤抑制蛋白(VHL)突变引起,VHL是一种E3泛素连接酶复合物的组成部分,该复合物靶向羟基化的HIF进行降解。最近一份关于家族性红细胞增多症的报告现在涉及另一种蛋白质,脯氨酰羟化酶结构域蛋白2(PHD2),它是一种使HIF羟基化的酶。